New Company Formed with $130 Million to Accelerate Duke’s Drug Discovery

DURHAM, N.C., and NEW YORK, N.Y. — Duke University and Deerfield Management Company, a healthcare investment firm,  announced Wednesday the creation of a major translational research collaboration.  Spearheaded by Duke University’s Office of Licensing & Ventures (OLV), the alliance is expected to accelerate Duke’s preclinical development of new drugs for improved quality of life and cures for…

Read the full article here

Related Articles